Harley-Davidson
- Market cap
- 2.80B
- P/E (TTM)i
- 14.97
- P/Bi
- 0.91
- EPSi
- 2.78
- Div yieldi
- 2.73%
- 52W posi
- 86%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership rose 1.2 percentage points.
Institutional ownership
- Held by institutions
- 110.75% +1.20pp
- Institutions
- 503 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 35 buys · 15 sells
| Name | Role | Stake |
|---|---|---|
| Jochen Zeitz | Chairperson & CEO | 0.66% |
| Daniel Nova | Independent Director | 0.05% |
| Jonathan Root | Chief Financial Officer | 0.04% |
| Troy Alstead | Independent Director | 0.04% |
| Paul Krause | VP, Chief Legal & Compliance Officer and Secretary | 0.03% |
| Norman Linebarger | Independent Director | 0.03% |
| Jagdish Krishnan | Chief Digital & Operations Officer | 0.03% |
| Maryrose Sylvester | Independent Director | 0.03% |
| Arthur Starrs | Chief Executive Officer | 0.02% |
| James Farley | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Jonathan Root | Chief Financial Officer | Automatic Disposition | -1,559 | $24.43 |
| 2026-09-23 | Daniel Nova | Independent Director | Derivative Exercise and Retained | +5,168 | -- |
| 2026-08-31 | Jonathan Root | Chief Financial Officer | Automatic Disposition | -1,554 | $27.46 |
| 2026-08-12 | Paul Krause | VP, Chief Legal & Compliance Officer and Secretary | Intent to Sell (Form 144) | -3,750 | $26.85 |
| 2026-08-10 | Gayle Littleton | Chief Legal, Compliance & Corporate Affairs Officer and Corporate Secretary | Open Market Acquisition | +7,500 | $26.38 |
| 2026-08-09 | Arthur Starrs | Chief Executive Officer | Open Market Acquisition | +10,000 | $25.89 |
| 2026-08-02 | Jonathan Root | Chief Financial Officer | Automatic Disposition | -1,554 | $24.88 |
| 2026-07-30 | Daniel Nova | Independent Director | Open Market Acquisition | +40,000 | $24.57 |
| 2026-07-23 | Gayle Littleton | Chief Legal, Compliance & Corporate Affairs Officer and Corporate Secretary | Other Derivative Acquisition | +39,232 | -- |
| 2026-06-30 | Jonathan Root | Chief Financial Officer | Automatic Disposition | -1,554 | $24.44 |
| 2026-06-03 | James Farley | Independent Director | Intent to Sell (Form 144) | -16,205 | $24.25 |
| 2026-05-31 | Jonathan Root | Chief Financial Officer | Automatic Disposition | -1,554 | $23.87 |
| 2026-05-20 | Daniel Nova | Independent Director | Other Acquisition | +4,742 | -- |
| 2026-05-20 | Daniel Nova | Independent Director | Other Derivative Acquisition | +6,520 | -- |
| 2026-05-20 | Troy Alstead | Independent Director | Other Derivative Acquisition | +6,250 | -- |
| 2026-05-20 | Maryrose Sylvester | Independent Director | Other Derivative Acquisition | +6,250 | -- |
| 2026-05-20 | Allan Golston | Independent Director | Other Derivative Acquisition | +6,250 | -- |
| 2026-05-20 | Matthew Reintjes | Independent Director | Other Acquisition | +2,479 | -- |
| 2026-05-20 | Matthew Reintjes | Independent Director | Other Derivative Acquisition | +6,250 | -- |
| 2026-05-20 | Lori Flees | Independent Director | Other Derivative Acquisition | +8,621 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:37:05 · For reference only, not investment advice and not tailored to your situation.